调节食欲的新型药物:探索新兴肠道和它们的药理学前景
Igor Rubinić1,2, Marija Kurtov3, Robert Likić4
1Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Pharmacology research & perspectives
|July 17, 2024
概括
针对肠道的创新制药策略为肥胖管理提供了新的希望. 研究正在探索格林,酸YY (PYY),胆囊托基宁 (CCK) 和氨酸,以寻找有效的抗肥胖疗法.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 肥胖是一个重要的全球健康问题,需要新的治疗策略.
- 肠道在调节食欲和能量平衡方面发挥着至关重要的作用.
- 一些肠道,包括格林,PYY,CCK和氨酸,是抗肥胖药物开发的有希望的目标.
研究的目的:
- 审查针对肥胖的药物治疗目标肠道的潜力.
- 讨论各种制药方法,包括基于和基于小分子的药物.
- 突出这些疗法开发的进展和挑战.
主要方法:
- 关于肠道和它们在食欲调节中的作用的现有文献的综述.
- 对针对氧化和无氧化肠道的不同药理策略的分析.
- 对基于的抗肥胖剂的临床试验进展的审查.
主要成果:
- 格林是一种氧化,可以通过中和,受体对抗或抑制格林O-转移酶来向格林.
- 厌食性酸PYY,CCK和氨酸表现出降低食欲的作用.
- 氨基林类似物和双重激动剂正在进行先进的临床试验,显示出显著的前景.
结论:
- 向肠道体是肥胖药物治疗中的一个有希望的前沿.
- 克服稳定性和输送等挑战对于临床成功至关重要.
- 创新的制药策略,特别是涉及氨酸的药物,为未来的肥胖治疗提供了充满希望的前景.
相关概念视频
Regulation of Food Intake
216
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
216
Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
Hormonal Regulation
43.3K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.3K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
244
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
244
Regulation of the Digestive System
504
Digestive activity regulation hinges on three primary components. Activation is prompted by a multitude of mechanical and chemical indicators, primarily detected by receptors within the stomach and intestines' walls. These receptors predominantly respond to factors such as mechanical stretching of the organ walls, changes in pH and osmolarity, and the presence of digesting materials and their by-products.
The effectors in this regulation system are glands and smooth muscles. Activation of...
The effectors in this regulation system are glands and smooth muscles. Activation of...
504
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


